No takes yet. Share an insight, caveat, or question.
Randomized trial examines death causes in women after extended adjuvant endocrine therapy for breast cancer, indicating significant non-cancer mortality.
Chapman et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: